Atlas Trials

A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients

Clinical trial NCT00543569 · COMPLETED

Trial details

NCT number
NCT00543569
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Transplantation
Start date
2008-02-01
Primary completion
2011-02-01
Enrollment
323

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.